ASX · PTX.AX
Prescient Therapeutics Limited
A$0.05-A$0.00 (-1.82%)
Prescient Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 56.8% below the high.
Loading market information…
ASX · DOC.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 01:50 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Doctor Care Anywhere Group PLC’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Doctor Care Anywhere Group PLC’s next earnings report is currently expected on Mar 4, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Doctor Care Anywhere Group PLC’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom and the Republic of Ireland. It offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health assessments, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joint, muscles, lifestyle support, men’s and women’s health, mental health, sexual health, and skin conditions. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -A$0.02 |
| A$36.09M-21.54% vs estimate |
| Q2 2023 | Apr 27, 2023 | -A$0.02 | A$36.50M+5.24% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.05-A$0.00 (-1.82%)
Prescient Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 56.8% below the high.
A$0.26+A$0.01 (+2.0%)
Mach7 Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 62.77% below the high.
A$1.22A$0.00 (0.0%)
Cryosite Limited’s quoted price sits in the upper half of its reported 52-week range, 12.86% below the high.
A$0.47A$0.00 (0.0%)
CleanSpace Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.49% below the high.
A$0.04+A$0.00 (+2.56%)
Emyria Limited’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
A$0.05A$0.00 (0.0%)
NeuroScientific Biopharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.
A$0.07A$0.00 (0.0%)
Beamtree Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 68.44% below the high.
A$0.12+A$0.00 (+2.56%)
Proteomics International Laboratories Ltd.’s quoted price sits in the lower half of its reported 52-week range, 86.05% below the high.
